Portal de Periódicos da CAPES

Mature Myeloid Dendritic Cells for Clinical Use Prepared from CD14 + Cells Isolated by Immunomagnetic Adsorption

2001; Mary Ann Liebert, Inc.; Volume: 10; Issue: 3 Linguagem: Inglês

10.1089/152581601750289037

2168-6580

Douglas Padley, Allan B. Dietz, Dennis A. Gastineau, Stanimir Vuk‐Pavlović,

T-cell and B-cell Immunology

Journal of Hematotherapy & Stem Cell ResearchVol. 10, No. 3 Rapid CommunicationMature Myeloid Dendritic Cells for Clinical Use Prepared from CD14+ Cells Isolated by Immunomagnetic AdsorptionDouglas J. Padley, Allan B. Dietz, Dennis A. Gastineau, and Stanimir Vuk-PavlovićDouglas J. Padley, Allan B. Dietz, Dennis A. Gastineau, and Stanimir Vuk-PavlovićPublished Online:9 Jul 2004https://doi.org/10.1089/152581601750289037AboutSectionsPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail FiguresReferencesRelatedDetailsCited ByDendritic Cells Transfected with Adenoviral Vectors as Vaccines3 February 2014Comparative evaluation of techniques for the manufacturing of dendritic cell-based cancer vaccines17 March 2008 | Journal of Cellular and Molecular Medicine, Vol. 13, No. 1Cellular immunotherapy (CI), where have we been and where are we going?Closing the manufacturing process of dendritic cell vaccines transduced with adenovirus vectorsInternational Immunopharmacology, Vol. 8, No. 13-14Isolation of monocytes from leukapheretic products for large-scale GMP-grade generation of cytomegalovirus-specific T-cell lines by means of an automated elutriation deviceTransfusion, Vol. 48, No. 8Monocyte enrichment from leukapheresis products by using the Elutra cell separatorTransfusion, Vol. 47, No. 12Preparing clinical-grade myeloid dendritic cells by electroporation-mediated transfection of in vitro amplified tumor-derived mRNA and safety testing in stage IV malignant melanoma15 August 2006 | Journal of Translational Medicine, Vol. 4, No. 1Induction of cellular immune responses against carcinoembryonic antigen in patients with metastatic tumors after vaccination with altered peptide ligand-loaded dendritic cells21 July 2005 | Cancer Immunology, Immunotherapy, Vol. 55, No. 3Closed system generation of dendritic cells from a single blood volume for clinical application in immunotherapy1 January 2005 | Journal of Clinical Apheresis, Vol. 20, No. 4The large scale generation of dendritic cells for the immunization of patients with non-small cell lung cancer (NSCLC)Lung Cancer, Vol. 47, No. 3Immunotherapy of Cancer by Dendritic Cell-Targeted Gene TransferClinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanomaCytotherapy, Vol. 6, No. 6Apoptosis of monocytes and the influence on yield of monocyte-derived dendritic cellsJournal of Immunological Methods, Vol. 294, No. 1-2Generation of Dendritic Cells from Positively Selected CD14 + Monocytes for Anti-tumor Immunotherapy3 August 2009 | Leukemia & Lymphoma, Vol. 45, No. 7Clinical-Scale Generation of Dendritic Cells in a Closed SystemJournal of Immunotherapy, Vol. 26, No. 4Generation of dendritic cells from CD14 + monocytes positively selected by immunomagnetic adsorption for multiple myeloma patients enrolled in a clinical trial of anti-idiotype vaccination9 April 2003 | British Journal of Haematology, Vol. 121, No. 2Monocyte enrichment from leukapharesis products for the generation of DCs by plastic adherence, or by positive or negative selectionCytotherapy, Vol. 5, No. 5 Volume 10Issue 3Jun 2001 To cite this article:Douglas J. Padley, Allan B. Dietz, Dennis A. Gastineau, and Stanimir Vuk-Pavlović.Mature Myeloid Dendritic Cells for Clinical Use Prepared from CD14+ Cells Isolated by Immunomagnetic Adsorption.Journal of Hematotherapy & Stem Cell Research.Jun 2001.427-429.http://doi.org/10.1089/152581601750289037Published in Volume: 10 Issue 3: July 9, 2004PDF download